Reflection paper on the dissolution specification for ...
1.1. Scope In the context of this reflection paper immediate release is identified as at least 75% (Q) of the active substance is dissolved within 45 minutes.
Download Reflection paper on the dissolution specification for ...
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
fDA Guidance for Industry Dissolution Testing of …
www.dissolutiontech.comFDA Immediate Release Guidance ... continued BIDPHARMACEUTICS CLASSIFICATION SYSTEM Based on drug solubility and permeability, thc following
Dissolution Testing of a Controlled- Release …
www.dissolutiontech.com6 Dissolution Technologies | MAY 2013 Dissolution Testing of a Controlled-Release Capsule Formulation: Challenges and Solutions Using a Semi-Automated Dissolution System
Reflection paper on the dissolution specification …
www.ema.europa.euconsidered: 80 • Selection of a suitable dissolution medium should be based on the physico- chemical characteristics 81 of the active substance(s) and the intended dose range of the drug pr oduct to be tested.
ASEAN GUIDELINE ON STABILITY STUDY OF DRUG …
www.hsa.gov.sg5th Draft 1 1. INTRODUCTION 1.1 Stability is an essential factor of quality, safety and efficacy of a drug product. Insufficient stability of a drug product can result in changes in physical (like hardness,
Lorvacs XL 1.5 mg Prolonged-release Tablets PL …
www.mhra.gov.ukMHRA PAR; LORVACS XL 1.5 MG PROLONGED-RELEASE TABLETS, PL 27900/0001 2 LORVACS XL 1.5 MG PROLONGED-RELEASE TABLETS PL 27900/0001 LAY SUMMARY The Medicines and Healthcare products Regulatory Agency (MHRA) granted a
Guideline for Bioequivalence Studies of Generic …
www.nihs.go.jp3 B. Oral extended release products I. Reference and test products II. Bioequivalence studies 1. Test method 2. Assessment of bioequivalence 1) Bioequivalence range, parameters, data transformation and statistical
ORAL DRUG DELIVERY
www.ondrugdelivery.comwww.ondrugdelivery.com oral drug delivery: formulation selection methods & novel delivery technologies outstanding issue sponsor
Related search queries
FDA Guidance for Industry Dissolution Testing of, Immediate Release, Dissolution Testing, Release, Dissolution, Controlled-Release Capsule Formulation: Challenges and Solutions, Paper on the dissolution specification, ASEAN GUIDELINE ON STABILITY STUDY OF, Mg Prolonged-release Tablets PL, MG PROLONGED-RELEASE TABLETS, PL 27900, MG PROLONGED-RELEASE TABLETS PL 27900, Guideline for Bioequivalence, Oral drug delivery